NutryFarm International Limited Overview
NutryFarm International is a Bermuda-incorporated, SGX-Mainboard shell-in-transformation. For most of the past decade it was a Chengdu-based maker of herbal nutrition and health-food products, sold through its subsidiary NutryFarm (Chengdu) Biomedicine. In 2021 it made a short-lived, contentious diversification into Thai durian trading. Governance failures, impaired related-party advances and an unpayable debt load then pushed it into court-supervised judicial management from June 2022 to February 2026. The legacy operating businesses have been disposed of or deconsolidated. The group is now attempting a reverse-turnaround into AI and data-centre infrastructure through its subsidiary AI Nova Pte. Ltd., which offers cloud GPU, connectivity and data-centre consultancy services across Singapore, Malaysia, Indonesia and China. AI Nova reports a contract pipeline of about US$400M and a US$65.2M customer receipt in September 2026. The equity case depends on SGX approving resumption, a highly dilutive creditor debt-for-equity conversion, and verification of a single, undisclosed anchor customer.
The company's own description (latest annual report)
The FY2024 Annual Report describes the company as a Bermuda-incorporated investment holding company listed on the SGX Mainboard. It says the company is repositioning, after restructuring under judicial management, as a diversified platform in technology infrastructure (AI and data centres) across Southeast Asia and China [AR24]. The FY2023 Annual Report, published two months earlier, also included agri-commodities trading in this description. That element was dropped from the FY2024 wording [AR23 vs AR24].
The CEO's message in the FY2024 AR says AI Nova's core activities are:
-
Cloud GPU services
-
Enterprise connectivity solutions
-
Service-based operations
-
Data-centre consultancy, including AI consulting, Internet Data Centre (IDC) consulting and managed services
It cites a contract pipeline of approximately US$400 million. It also says the group is pursuing data-centre operations and infrastructure projects in Singapore, Malaysia, Indonesia and the PRC [AR24].
Independent characterisation
Business model, current. AI Nova is best described as an asset-light reseller and integrator of high-performance cloud computing capacity, not yet an owner-operator of data centres. Monthly updates from October 2025 describe several elements:
-
AI Nova's new business segments: high-performance computing equipment leasing, data-centre and warehouse operation and maintenance, and Singapore telecommunications services [MC, 29 Oct 2025]
-
A first service agreement (24 June 2025) to supply cloud computing and maintenance services
-
A second service agreement (25 July 2025) to supply cloud, maintenance and support services to a third-party customer
-
A parent-company continuing guarantee (2 September 2025) in favour of the upstream service provider
Together these point to a back-to-back structure. AI Nova contracts capacity from an upstream provider, with a parent guarantee, and resells it to an end customer. Margin capture depends on the spread between the two contracts. Neither counterparty has been publicly identified [MC, 7 Oct 2026].
Revenue model. The model is service and contract-based, with multi-year terms. The main services agreement was extended to 60 months, ending 30 November 2030 [MC, 7 Oct 2026]. This resembles infrastructure-as-a-service subscription revenue. No product, licensing or subscription mix has been disclosed. FY2024 group revenue was nil [AR24].
Value-chain position. AI Nova sits in the middle of the chain. Upstream are GPU and server owners and data-centre operators. Downstream are enterprise or AI customers.
Customer types and end-markets. The company targets enterprise AI and cloud workloads in Southeast Asia and China. Customer identities and creditworthiness are not publicly disclosed [MC, 7 Oct 2026].
Legacy model, through FY2022. NutryFarm (Chengdu) Biomedicine (NFC) operated 34,165.33 square metres of facilities in Sichuan. It researched, manufactured and marketed more than 40 self-manufactured nutrition and health-food products formulated from traditional medicinal herbs for PRC consumers [AR19]. From December 2020 the group also traded Thai fresh durians into China through Global Agricapital entities [PR, 17 Mar 2021]. NFC was disposed of in April 2023. FTI reported that this disposal was not authorised by the judicial manager [RegCo].
Strategy
Stated strategy (FY2024 AR themes, paraphrased)
-
Pivot to technology infrastructure, AI-related services and digital transformation across the region through AI Nova. Management cites demand for AI computing, cloud infrastructure and data localisation.
-
Build on the ~US$400M AI Nova contract pipeline, aiming for recurring revenue.
-
Develop and expand data-centre operations and infrastructure projects in Singapore, Malaysia, Indonesia and the PRC.
-
Resume trading on SGX through the ROTP, re-submitted 30 June 2025.
-
Restructure creditor obligations through debt conversion, disposal of distressed subsidiaries and assignment of rights to use.
-
Emphasise financial prudence, governance and rebuilding stakeholder confidence.
Source: [AR24].
Initiative register (last 24 months)
| Date | Initiative | Detail | Source |
|---|---|---|---|
| 12 Sep 2024 | Rebrand subsidiary to AI Nova | Platform for new businesses | [JM 11 Nov 2024] |
| 10 / 14 Oct 2024 | Alpha Hill S$5M loan and Corpbond supplementary deed | S$1.5M to AI Nova; S$0.3M for resumption costs; S$3.2M general working capital. Corpbond bears up to S$1M of resumption costs | [AR24] |
| 9 Apr 2025 (addendum 10 Oct 2025) | Implementation Agreement with Corpbond | Conversion shares, disposal of distressed subsidiaries, assignment of rights to use. Requires SGX, SIC and shareholder approvals | [AR24] |
| 24 Jun / 25 Jul 2025 | Cloud services agreements | First commercial contracts | [MC 29 Oct 2025] |
| Jul–Oct 2025 | AI Nova convertible loans | US$0.5M, 3 × US$5M and up to US$3M facilities at 7%, convertible at S$0.045 | [AR24] |
| 2 Sep 2025 | Parent continuing guarantee | Secures AI Nova obligations to its service provider | [MC 29 Oct 2025] |
| 7 Oct 2025 | Updated Forecast Memorandum to SGX | Reflects the changed AI Nova business model | [AR24] |
| 28 Oct 2025 / 28 Jul 2026 | SCA, then amended SCA | Tranche 1 S$27.37M at S$0.022 (pre-resumption). Tranche 2 S$6.90M at up to a 10% discount to post-resumption VWAP. Long-stop date 31 Dec 2026 | [AR24], [MC 31 Jul 2026] |
| Jul 2026 | Amended restructuring agreements; termination of US$1M loan agreements | Stated to have no material EPS/NTA impact | [MS], [MC 31 Jul 2026] |
| Apr–Sep 2026 | Subsidiary build-out | DC Green Development, AIDC Investor, HyperEdge Global, a PRC subsidiary and three others | [Ann 22 Apr 2026], [TR], [MS] |
| 7 Sep 2026 | Third amendment to services agreement | Term extended to 60 months; ~US$65.205M received | [MC 7 Oct 2026] |
Medium-term financial targets / guidance: none published. A Forecast Memorandum was submitted to SGX but has not been publicly released.
ESG commitments and cost-programme targets: none disclosed.
Products & Services
Current portfolio (AI Nova and related entities)
| Offering | Description | Target customer | Launch | Pricing model | Source |
|---|---|---|---|---|---|
| Cloud GPU / high-performance cloud computing services | Supply of cloud-based computing capacity, maintenance and support | Enterprise / AI workload customers (unnamed) | First service agreement 24 Jun 2025; second 25 Jul 2025 | Multi-year contract. Main agreement extended from 36 to 60 months (to 30 Nov 2030); ~US$65.205M received 30 Sep 2026. Unit pricing not disclosed | [MC 29 Oct 2025], [MC 7 Oct 2026] |
| HPC equipment leasing | Leasing of high-performance computing equipment | Enterprise | Business segment added Oct 2025 | — | [MC 29 Oct 2025] |
| Data-centre and warehouse operation & maintenance | O&M services | DC owners / operators | Oct 2025 | — | [MC 29 Oct 2025] |
| Telecommunication services (Singapore) | Voice, data and value-added services for enterprise and individual users | Singapore enterprise and retail | Oct 2025 | — | [MC 29 Oct 2025] |
| Enterprise connectivity solutions | Network connectivity | Enterprise | Disclosed 2026 | — | [AR24] |
| AI consulting / IDC consulting / managed services | Advisory on AI and internet data centres, plus managed services | DC developers, enterprises | Disclosed 2026 | — | [AR24] |
| Technical testing and analysis, including product and service certification | Testing services | — | Principal activity added Sep 2024 | — | [AR23] |
| Wholesale trade (non-dominant products) | General trading | — | Added Sep 2024 | — | [AR23] |
| Data-centre development (DC Green Development, AIDC Investor, HyperEdge Global) | Vehicles for DC-related investment and projects in Singapore, Malaysia, Indonesia and PRC | — | 2,026 | — | [AR24], [Ann 22 Apr 2026], [TR] |
No named product brands, platforms, GPU models, megawatt capacity or locations have been disclosed for any of these offerings.
Legacy portfolio (discontinued / disposed)
| Line | Description | Status | Source |
|---|---|---|---|
| Nutrition and health-food products | More than 40 self-manufactured products formulated mainly from traditional medicinal herbs from the Americas, China, Europe and New Zealand, sold to PRC consumers under the "Nutrition for health" philosophy | Disposed with NFC, Apr 2023 | [AR19] |
| Fresh durian trading (Thailand → China; Singapore retail JV) | Containerised fresh durian sourcing and sale. Orders included ~RMB130M for 200 containers fulfilled by 30 Apr 2021 and ~RMB195M for 300 containers in Jun 2021; Kong Jun Durian JV in Singapore | Wound down; subject of litigation | [PR], [Edge] |
| Internet management / WebTV technical support | LottVision-era internet services in China | Legacy | [Mkt: Morningstar] |
| Digital video surveillance products | LottVision-era products | Legacy | [Mkt: Yahoo profile] |
Financial Narrative
Basis. All figures are in HK$ thousand unless stated. FY2020 is an 18-month period (1 Apr 2019 – 30 Sep 2020). FY2021, FY2023 and FY2024 are 12 months to 30 September. FY2022 figures are as restated in the FY2023 AR, which moved the legacy business to discontinued operations. FY2020 and FY2021 figures are as originally presented in the FY2021 AR, before the discontinued-operations reclassification. Every year carries an auditor's disclaimer of opinion. Sources: FY2020–FY2021 [AR21]; FY2022–FY2023 [AR23]; FY2024 [AR24].
Income statement
FY2022 EPS is the sum of continuing (−48.51) and discontinued (−11.06) cents [AR23].
EBITDA. Depreciation and amortisation were disclosed for FY2020 (HK$3,833k) and FY2021 (HK$2,616k) only. That gives derived EBITDA of HK$-30,171k for FY2020 and HK$-98,125k for FY2021 [AR21]. Continuing-operations D&A is not disclosed for FY2022–FY2024. With a fixed-asset base of HK$22k–25k in FY2023–FY2024, EBITDA approximately equals EBIT in those years.
Margins. Margins can be computed only for years with revenue.
Revenue CAGR. A five-year CAGR is not meaningful. The base periods differ (an 18-month FY2020) and revenue falls to nil in FY2022 (restated) and FY2024. For the longer arc, see the legacy series below.
Legacy context. These are 12-month periods to 31 March, from the results announcements.
Sources: [R-FY18], [R-FY19]. The 12 months to 31 March 2020 recorded revenue of HK$37,820k [R-Q4FY20].
Commentary: trends, inflections and drivers.
-
Structural revenue decline, then collapse. Legacy nutrition revenue fell from HK$79.1M (FY2017) to HK$44.0M (FY2019). FY2021 revenue rose to HK$99.0M, partly because 2021 was the first full year of fruit trading. However, the FY2021 results were prepared after removing all Thai durian transactions overseen by the former CEO [R-FY21], [R-1Q22]. That is notable, because the company had publicly announced fulfilling ~RMB130M of durian orders by April 2021 alone [PR 21 Jun 2021]. Investors should regard the FY2021 top line as heavily adjusted.
-
Impairments drove the losses, not operations. Credit impairments of HK$98.6M in FY2021 and HK$35.1M in FY2022 explain most of the losses. These map to the Wang Xiaoxin advances (HK$59.8M still owed at 31 March 2022) and MLTY loans (RMB18.1M owed at 30 September 2021) identified by FTI [RegCo]. FY2021 gross profit of HK$30.8M shows the legacy business was still viable at the gross level.
-
Interest burden is now the whole P&L. In FY2024, finance costs of HK$15.2M equalled 103% of the net loss. Administrative costs fell 88% to HK$3.2M as the group shrank to a holding shell. The tiny positive EBIT of HK$427k in FY2024 comes from HK$3.6M of "other income", not operations.
-
The inflection is ahead. FY2025 (from June 2025 service agreements) and FY2026 (US$65.2M receipt in September 2026) should show the first AI Nova revenue. Neither has yet been reported. The receipt's accounting treatment (revenue, deferred revenue/contract liability, or financing) has not been disclosed.
Balance sheet
Goodwill and intangibles: HK$567k (FY2020) and HK$640k (FY2021); nil in FY2023–FY2024. The FY2022 intangible balance is not shown in the FY2023 AR highlights [AR21], [AR23], [AR24].
Commentary.
Assets largely gone: By FY2023 the group had shed essentially all assets. The NFC disposal removed PPE, inventories and receivables, leaving total assets of HK$1.0M against liabilities of HK$204.7M.
Corpbond is the core liability: Borrowings are dominated by the Corpbond facility. The October 2025 SCA sizes the debt owed to Corpbond at S$33.5M (principal plus interest to 30 June 2025), plus S$0.77M of assigned minority-creditor claims [AR24].
Parent-level deficit: At company level, net liabilities were HK$281.5M at FY2024 [AR24].
Post-balance-sheet changes: The FY2024 position predates the following:
-
The S$5M Alpha Hill loan (fully drawn)
-
AI Nova third-party loans: US$0.5M, three loans of US$5M each, and US$2M drawn of a US$3M facility, all at 7% and convertible at S$0.045 [AR24]
-
The ~US$65.2M customer receipt [MC 7 Oct 2026] The FY2025 and FY2026 balance sheets will therefore look very different.
Cash flow
Commentary.
FY2021 was funded by equity: The HK$41.3M of 2021 placement proceeds lifted year-end cash to HK$48.3M [AR21].
That cash then left the group: It drained through FY2022 operating outflows (HK$27.3M) and the FY2023 deconsolidation outflow (HK$33.7M) [AR23].
Minimal funding since: FY2023–FY2024 were funded by small third-party and related-party loans of HK$2–4M a year.
Ratios
All ratios are analyst-computed from the AR figures above.
Not meaningful:
Return metrics: ROE and ROIC: equity has been negative since FY2021, and invested capital is negative.
Leverage multiples: Debt/equity: 18.8x in FY2020, negative equity thereafter. Net debt/EBITDA: EBITDA is negative.
Cash conversion cycle: Revenue is too small or nil to support it.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Era Details
| Era | Reported segments | Notes | Source |
|---|---|---|---|
FY2018–FY2021 | (1) Internet Management: technical support for internet/WebTV; (2) Investment Holding: group investments and treasury; (3) Nutrition, Health Food & Related Health Products: manufacturing and trading, key revenue driver; (4) Fruits & Related Products: durian trading, added FY2021 | Revenue mostly PRC-derived; operations in Singapore, PRC, Thailand | [Mkt: Morningstar], [AR21] |
FY2022–FY2023 (restated) | Continuing operations vs discontinued operations. The legacy nutrition business (NFC) and other distressed subsidiaries were reclassified as discontinued. FY2022 comparatives were restated: FY2022 continuing revenue is nil | NFC disposed Apr 2023 | [AR23] |
FY2024 | Single continuing group with nil revenue; AI Nova pre-revenue | No segment revenue disclosed | [AR24] |
FY2026 (prospective) | Technology infrastructure: Cloud GPU, connectivity, data-centre consultancy (AI Nova and the AIDC Investor / HyperEdge Global / DC Green Development entities) | Not yet reported | [AR24], [TR] |
Results by Segment
| Metric | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
Continuing operations revenue (HKD K) | 0 | 4,080 | 0 |
Continuing operations gross profit (HKD K) | 0 | 219 | 0 |
Continuing operations loss before tax (HKD K) | -65,657 | -40,599 | -14,805 |
Discontinued operations loss (HKD K) | -15,797 | -28,996 | 0 |
Total loss (HKD K) | -81,454 | -69,595 | -14,805 |
Group Entities
| Entity | Jurisdiction | Function / status | Source |
|---|---|---|---|
AI Nova Pte. Ltd. (formerly Global Agricapital (Singapore) Pte. Ltd.) | Singapore | Core operating subsidiary: cloud GPU, connectivity, DC consultancy; S$1.5M capital injection 25 Oct 2024 | [AR24] |
AI Nova Sdn Bhd | Malaysia | MoU with Asas Panorama Sdn Bhd (aggregator-reported; terms not disclosed) | [Mkt: roic.ai] |
DC Green Development Pte. Ltd. | Singapore | Incorporated 22 Apr 2026, S$10,000 capital; directors Niu Liming and Tan Chui Eng | [Ann 22 Apr 2026] |
AIDC Investor Pte. Ltd. | Singapore | Incorporated 7 Jul 2026, S$10,000; directors Tan Chuan-Jin and Tan Chui Eng | [TR 15 Jul 2026] |
HyperEdge Global (Pte. Ltd.) | Singapore | Wholly owned by AIDC Investor; modest capital | [TR 15 Jul 2026] |
| — | PRC | Incorporated Aug 2026 | [MS] |
| — | — | Formed Sep 2026 | [MS] |
Global Agricapital (Thailand) Co., Ltd (GAT) | Thailand | Legacy durian unit; plaintiff against former CEO Cheng Meng in Bangkok | [AR24] |
LottVision (Hong Kong) Limited | Hong Kong | Guarantor of the 2017 Corpbond facility (legacy) | [Ann 30 Oct 2017] |
Lottvision Internet Management Ltd (China) | PRC | Legacy internet-management unit | [JM 2 Dec 2022] |
NutryFarm (Chengdu) Biomedicine / Agricultural Technology Co. (NFC) | PRC | Disposed Apr 2023 | [RegCo], [AR23] |
“—” = not publicly disclosed.
Income Statement and Per-Share Data
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Revenue (HKD K) | 61,568 | 98,995 | 0 | 4,080 | 0 |
Cost of sales (HKD K) | -39,692 | -68,214 | 0 | -3,861 | 0 |
Gross profit (HKD K) | 21,876 | 30,781 | 0 | 219 | 0 |
Net impairment losses on financial assets (HKD K) | -9,629 | -98,600 | -35,054 | -1,402 | 0 |
Administrative expenses (HKD K) | -40,840 | -28,412 | -21,298 | -26,397 | -3,219 |
Finance costs (HKD K) | -14,796 | -9,891 | -12,000 | -14,967 | -15,232 |
Operating income, EBIT (HKD K; analyst-derived as PBT + finance costs − interest income) | -34,004 | -100,741 | -53,657 | -25,633 | 427 |
Loss before tax, continuing (HKD K) | -48,394 | -110,528 | -65,657 | -40,599 | -14,805 |
Net loss, total (HKD K) | -48,512 | -111,453 | -81,454 | -69,595 | -14,805 |
EPS basic and diluted (HK cents) | -50.31 | -97.90 | -59.57 | -50.63 | -10.77 |
Dividends per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2020 | FY2021 | FY2023 |
|---|---|---|---|
Gross margin (%) | 35.5 | 31.1 | 5.4 |
EBIT margin (%) | -55.2 | -101.8 | -628.3 |
Net margin (%) | -78.8 | -112.6 | -1,705.8 |
Income Statement
| Metric | FY2017 | FY2018 | FY2019 |
|---|---|---|---|
Revenue (HKD K) | 79,053 | 66,896 | 44,042 |
Profit or loss before tax (HKD K) | 3,118 | -7,824 | -89,700 |
Net profit or loss (HKD K) | 1,527 | -8,280 | -91,593 |
Balance Sheet
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Total assets (HKD K) | 184,812 | 135,878 | 94,645 | 1,014 | 1,858 |
Cash and bank balances (HKD K) | 8,689 | 48,290 | 34,423 | 48 | 620 |
Short-term borrowings (HKD K) | 55,068 | 97,848 | 153,106 | 148,065 | 159,231 |
Long-term borrowings (HKD K) | 83,545 | 43,594 | 0 | 0 | 0 |
Total borrowings (HKD K) | 138,613 | 141,442 | 153,106 | 148,065 | 159,231 |
Net debt (HKD K) | 129,924 | 93,152 | 118,683 | 148,017 | 158,611 |
Trade and other payables (HKD K) | 36,817 | 50,806 | 70,502 | 56,603 | 74,690 |
Total liabilities (HKD K) | 177,457 | 196,598 | 228,123 | 204,672 | 233,921 |
Total equity or deficit (HKD K) | 7,355 | -60,720 | -133,478 | -203,658 | -232,063 |
Working capital (HKD K) | 42,598 | -34,262 | -148,536 | -203,699 | -232,092 |
Property, plant and equipment (HKD K) | 46,582 | 15,294 | 13,986 | 25 | 22 |
Inventories (HKD K) | 8,008 | 16,642 | 15,300 | 0 | 0 |
Cash Flow
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Operating cash flow (HKD K) | 3,346 | -3,404 | -27,340 | -4,706 | -2,181 |
Capital expenditure (HKD K) | 16,861 | 3,091 | 9 | 11 | 0 |
Free cash flow (HKD K) | -13,515 | -6,495 | -27,349 | -4,717 | -2,181 |
Dividends paid (HKD K) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (HKD K) | 0 | 0 | 0 | 0 | 0 |
Equity issuance proceeds (HKD K) | 0 | 41,299 | 0 | 0 | 0 |
Net financing cash flow (HKD K) | -12,294 | 38,575 | 16,779 | 4,070 | 2,753 |
Financial Ratios (x)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Current ratio (x) | 1.45 | 0.78 | 0.35 | 0.005 | 0.008 |
Interest coverage, EBIT over finance costs (x) | -2.30 | -10.19 | -4.47 | -1.71 | 0.03 |
Net debt to total assets (x) | 0.70 | 0.69 | 1.25 | 145.97 | 85.37 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
ROA on average total assets (%) | -69.5 | -70.7 | -145.5 | -1,031.0 |
Asset turnover on average total assets (x) | 0.62 | 0.00 | 0.09 | 0.00 |
Revenue by Region
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
Group revenue, all regions (HKD K) | 98,995 | 0 | 4,080 | 0 |
Region Overview
| Region | Historic role | Current / prospective role | Trend |
|---|---|---|---|
PRC (Sichuan / Chengdu) | Manufacturing and sales of nutrition products; durian import destination | NFC disposed Apr 2023; AI Nova targets PRC DC projects; new PRC subsidiary Aug 2026 | Declined to nil; may re-emerge |
Thailand | Durian sourcing via GAT | Litigation only (Bangkok South Civil Court) | Declined to nil |
Singapore | Listing venue; Kong Jun durian JV | AI Nova HQ, telecom services, DC Green Development, AIDC Investor, HyperEdge Global | Fastest-growing (from zero) |
Malaysia | — | AI Nova Sdn Bhd; MoU with Asas Panorama Sdn Bhd | Emerging |
Indonesia | — | Targeted DC projects | Prospective |
Hong Kong | Principal office | Office relocated to Singapore by FY2024 AR | Declined |
Data Point Details
| Data point | Value | Date | Source |
|---|---|---|---|
Last traded price | 0.085 | Before suspension on 11 Apr 2022 | [Mkt], [Edge] |
All-time high | 0.510 | 22 Jun 2021 | [Mkt: TradingView] |
All-time low | 0.031 | 31 Mar 2020 | [Mkt: TradingView] |
Sharp drop before suspension | 0.22 → 0.14 (−36.4%) on 221% higher volume | Early 2022, cited by SGX RegCo | [Edge] |
Placement price | 0.29 | Jun 2021 | [Edge] |
SCA Tranche 1 conversion price | 0.022 | Oct 2025 | [AR24] |
AI Nova loan conversion price | 0.045 | 2025 | [AR24] |
Alpha Hill loan conversion price | 0.015 | Oct 2024 | [AR24] |
Share Count (millions)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Shares outstanding at year-end (millions) | 96.42 | 137.42 | 137.42 | 137.42 | 137.42 |
Dividends per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Capital Instruments
| Instrument | Amount | Maturity | Terms | Source |
|---|---|---|---|---|
Corpbond debt (2017 facility plus assigned claims) | S$34.27M | To be converted (long-stop 31 Dec 2026) | Tranche 1 S$27.37M at S$0.022; Tranche 2 S$6.90M post-resumption | [AR24], [MC] |
Alpha Hill loan | S$5.0M | 5 years from disbursement (~2029) | Interest-free; convertible at S$0.015 | [AR24] |
AI Nova loan | US$0.5M | 2 years (~2027) | 7%; convertible at S$0.045 | [AR24] |
AI Nova loans | US$5.0M + US$5.0M + US$5.0M | 1, 2 and 3 years (~2026–2028) | 7%; convertible at ≤S$0.045 | [AR24] |
AI Nova loans (3 × US$1M) | US$2M drawn | 2 years (~2027) | 7%; US$1M facility terminated Jul 2026 | [AR24], [MC] |
Analyst Conclusions
Management guidance: none published. The Forecast Memorandum submitted to SGX (7 October 2025) has not been released. Management frames the outlook around the ~US$400M pipeline and regional DC expansion [AR24].
Consensus growth expectations: none; no analyst coverage.
Bull case
-
Contracted cash is real. The US$65.2M receipt and 60-month term to 2030 suggest a counterparty with genuine demand and recurring revenue potential against a ~S$12M market cap [MC 7 Oct 2026].
-
Balance sheet can be reset. Converting S$34.27M of Corpbond debt plus the convertible loans would remove nearly all of the HK$159M borrowings, leaving a clean, listed AI-infrastructure vehicle [AR24].
-
Credible board, real growth market. The board now has relevant cloud and finance credentials, and the Malaysian DC market is projected to nearly double by 2031 [AR24], [Ind].
Bear case
-
Unverifiable economics. Five consecutive audit disclaimers, an undisclosed customer and an unexplained receipt mean the core economics cannot be verified [AR24], [MC].
-
Minorities are crowded out. Tranche 1 conversion at S$0.022 (74% below the last trade) gives the converting creditor ~90% before other conversions [AR24].
-
Governance contest unresolved. The CEO's Corpbond affiliation, an open SGX RegCo investigation and an active SGM/proxy dispute signal unresolved control conflict [AR24], [RegCo], [TR].
Catalysts and monitorables (next 12 months)
SGX decision on the ROTP: This determines whether trading resumes.
Restructuring completion by 31 Dec 2026: SCA long-stop date, plus SIC whitewash and shareholder approvals.
Outstanding accounts: Publication of FY2025 and FY2026 accounts, including the accounting treatment of the US$65.2M receipt and whether the disclaimer is lifted.
The requisitioned SGM: Its outcome on board and CEO changes.
Investigations and litigation: Progress of the SGX RegCo investigation and the High Court claim.
Business disclosures: Any naming of the customer or upstream provider, MW capacity, and DC project sites in Malaysia, Indonesia or the PRC.
Analyst verdict.
NutryFarm International is no longer the herbal-supplements company its name implies. It is a post-insolvency listed shell being repurposed, under creditor sponsorship, into an AI cloud and data-centre services vehicle. The historical record is poor:
-
A decade of revenue decline in the legacy business
-
HK$98.6M of FY2021 credit impairments traced to undocumented, interest-free advances
-
A durian venture whose transactions had to be stripped out of the accounts
-
Allegedly unauthorised settlement agreements worth RMB334M
-
A disposal of the main subsidiary that the judicial manager did not authorise
SGX RegCo's December 2025 judgement that governance fell short of expected standards is fair.
The transformation, however, is not imaginary. Judicial management ended in February 2026. Minority creditor claims were consolidated into a single creditor. A reconstituted board includes genuine cloud expertise. Most strikingly, AI Nova received about US$65.2M from a customer under a contract extended to 2030. If the receipt and margins are verified, the operating subsidiary could quickly dwarf the parent's liabilities.
The difficulty is the gap between those signals and auditable fact. No set of accounts since FY2019 carries a clean opinion. The customer, the supplier and the margin structure are undisclosed. The parent guarantees the upstream supplier, and FY2025 numbers are outstanding. For existing minority shareholders, the capital structure is decisive. Conversion at S$0.022, against a last trade of S$0.085, transfers roughly nine-tenths of the equity to the creditor group led by entities the CEO is associated with. That happens before the Alpha Hill (S$0.015) and AI Nova (S$0.045) conversions.
Verdict: a high-risk, binary special situation, uninvestable on fundamentals until three things happen: (1) SGX approves resumption on the basis of audited, unqualified accounts; (2) the anchor contract's counterparty and economics are disclosed; and (3) the October 2026 control dispute is resolved. Equity value for current holders is likely to be heavily diluted even in the success case.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Appointed | Committees | Background |
|---|---|---|---|---|
Niu Liming | Executive Director and CEO | 19 Dec 2022; re-appointed 5 Dec 2025 and 31 Mar 2026 | NC, RC member | Director of Corpbond Holdings Pte Ltd and Corpbond Investments Pte Ltd (Corpbond is the company's largest creditor and JM applicant). 20+ years in M&A, restructuring, private equity. MBA (Strathclyde), MSc (Chinese Academy of Sciences), BSc (Qingdao University). Age not disclosed |
Wan Tai Foong | Lead Independent Director | 31 Mar 2026 | AC Chair; NC, RC | 25+ years in investment banking (Rabobank International, KCB Bank Singapore, Kim Eng Corporate Finance, N M Rothschild & Sons Singapore; started at Arthur Andersen). Founder and CEO of Qi Capital Pte Ltd. BCom (Murdoch), CPA Australia |
Er Kwong Wah | Independent Director | 23 May 2023; re-appointed 2025 and 2026 | NC Chair; AC, RC | 27 years in Singapore civil service; former Permanent Secretary (Education, then Community Development). Former directorships at Sembawang Marine & Logistics, Sembcorp Industries, COSCO Shipping International (Singapore); currently ID of Luxking Group and Metech International. BASc (Toronto), MBA (Manchester) |
Ng Chern Nee | Independent Director | 5 Dec 2025; re-appointed 31 Mar 2026 | RC Chair; NC, AC | 30+ years in AI, cloud, cybersecurity, telecoms. Former MD (Singapore & Malaysia) Google Cloud; GM Public Sector, Microsoft Asia Pacific; founder of Singlife Philippines. BBA (NTU) |
Executive Leadership Team
| Name | Role | Since | Source |
|---|---|---|---|
Niu Liming | CEO | Dec 2022 | [AR24] |
Derek Ong Chee Beng | Group Financial Controller (age 60 per aggregator) | 8 Jun 2026 | [MS] |
Tan Chui Eng | Director of DC Green Development and AIDC Investor (subsidiary level) | 2026 | [Ann 22 Apr 2026], [TR] |
Tan Chuan-Jin | Director of AIDC Investor Pte. Ltd. (subsidiary level) | Jul 2026 | [TR 15 Jul 2026] |
Virtus Law LLP | Company Secretary | 3 Mar 2025 | [AR21] |
Board & Management Changes
| Date | Change | Source |
|---|---|---|
14 Oct 2019 / 6 Feb 2020 | Terence Luk becomes ED, then CEO | [AR21] |
6 Jan 2021 | Cheng Meng becomes CEO; Luk re-designated Non-Executive Chairman | [AR21] |
30 Dec 2021 | Xu Hai Min resigns as NED | [AR21] |
11 Feb 2022 | Cheng Meng steps down as CEO (remains ED to 1 Apr 2022) | [AR21] |
Mar–Oct 2022 | Neo Chee Beng (1 Mar), Lee Pih Peng (21 Mar), Ng Poh Khoon Jimmy (23 Sep), Terence Luk (3 Oct) and Lim Swee Hua David (12 Oct) resign | [AR21], [AR23] |
May 2022 | Wu Yongqiang signs results as Executive Chairman; later resigns (Edge reports chairman's resignation) | [R-FY21], [Edge] |
19 Dec 2022 | Niu Liming appointed ED/CEO; Ng Fang Yao and Luo Shi Yao cease | [AR23] |
23 May 2023 | Er Kwong Wah, Hwang Kin Soon Ignatius and Seah Chee Wei appointed | [AR23] |
Jan / Mar 2024 | Seah Chee Wei (15 Jan) and Hwang (10 Mar) cease | [AR24] |
5 Dec 2025 | Goodchild, Ng Chern Nee and Kelvin Chow appointed | [AR23] |
31 Mar 2026 | Wan Tai Foong appointed Lead ID | [AR24] |
9 Oct 2026 | Shareholders (≥10%) requisition an SGM to remove a director, appoint In Nanny Sing Charlie and potentially change the CEO | [TR 9 Oct 2026] |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Relevance / scale (where sourced) | Source |
|---|---|---|---|
AI cloud / sovereign AI, Malaysia | YTL Power International (YTL AI Cloud) | Strategic agreement with NVIDIA valued at RM10B (~US$2.36B) for AI data centres; Johor campus of up to 72MW | [Ind: DCD, w.media] |
GPU-as-a-service, Malaysia | IP ServerOne (NovaGPU) | Managed GPUaaS with Malaysian data residency; Sarawak region live | [Ind: IPServerOne] |
AI compute centres, Malaysia | Malton Bhd / Ricloud AI (NVIDIA Cloud Partner) | MoU to build AI compute centres | [Ind: BusinessToday MY, FocusMalaysia] |
APAC neocloud | Sharon AI (Nasdaq: SHAZ) | US$1.32B five-year cloud compute contract with a global AI lab; 132MW AI-factory capacity | [Ind: BusinessWire] |
Hyperscale cloud | Amazon Web Services, Microsoft Azure, Google Cloud | Dominant regional cloud providers (scale figures not sourced here) | General industry knowledge |
SEA data-centre operators | ST Telemedia Global Data Centres, Princeton Digital Group, AirTrunk, Singtel (Nxera), Keppel DC | Major DC landlords and operators (figures not sourced here) | General industry knowledge |
Legacy: PRC nutrition supplements | By-health, Tomson and other PRC health-food makers | Historical only | General industry knowledge |
Peer Comparison FY2024
| Metric | NutryFarm (FY2024) | YTL Power | Sharon AI | IP ServerOne |
|---|---|---|---|---|
Revenue | HK$0 | — | — | Private: not publicly disclosed |
Flagship AI contract | Undisclosed customer; ~US$65.2M received; 60-month term | RM10B NVIDIA partnership | US$1.32B, 5 years | — |
Owned DC capacity | None disclosed | Up to 72MW (Johor campus) | 132MW AI-factory capacity | Multiple Malaysian regions |
Gross margin / R&D intensity | Not meaningful / not disclosed | — | — | — |
Balance sheet | Net liabilities HK$232.1M | Large-cap utility group | Raised US$1.6B in 2026 | Private |
“—” = not publicly disclosed.
Recent Developments
--



